Algisum 500 mg+100 mg (Chewable Tablet)

Indications

• Treatment of acid reflux symptoms
• Management of heartburn
• Relief from indigestion
• Usage during pregnancy
• Treatment for laryngopharyngeal reflux
• Symptomatic relief after gastric surgery

Pharmacology

• Combination of Sodium Alginate and Potassium Bicarbonate
• Formation of gel in stomach
• Creation of carbon dioxide bubbles
• Raft formation to block acid reflux into esophagus
• Non-systemic circulation action
• 4-hour raft duration

Dosage & Administration

• Tablet and Suspension forms
• Different dosages for adults and children
• Specific dosages for different age groups
• Usage after meals and bedtime
• No usage under 2 years of age
• No dose modifications for elderly, hepatic impairment
• Caution for renal insufficiency and restricted salt diet

Interaction

• Consideration of 2-hour time interval with other medicinal products
• Avoidance with specific medications like tetracyclines, fluoroquinolones, iron salts
• Caution during intake of thyroid hormones, chloroquine, bisphosphonates, estramustine

Contraindications

• Hypersensitivity to sodium alginate and potassium bicarbonate

Side Effects

• Possible nausea, constipation, diarrhea, headache
• Consultation for excessive dosage or swelling sensation

Pregnancy & Lactation

• Clinical usage during pregnancy
• No known effect on breast-fed infants
• Usage during breastfeeding

Precautions & Warnings

• Prescription caution for renal impairment, congestive cardiac failure
• Care for hypercalcemia, nephrocalcinosis, recurrent renal calculi
• Efficacy review after 7 days if no improvement
• Reduced efficacy with very low gastric acid levels

Overdose Effects

• Rare cases of overdosage
• Consultation with registered physician for overdose

Therapeutic Class

• Antacids

Storage Conditions

• Temperature maintenance below 30°C
• Protection from light and moisture
• Keep out of reach of children

Related Brands

• Algicid (500 mg+100 mg)/5 ml (Oral Suspension) - incepta-pharmaceuticals-ltd